We are live on
!
Find out more
PCM
Palouse Capital Management Portfolio holdings
AUM
$160M
1-Year Est. Return
36.15%
This Fund
S&P 500
This Quarter
Est. Return
-12.53%
1 Year Est. Return
+36.15%
3 Year Est. Return
+67.75%
5 Year Est. Return
+68.17%
10 Year Est. Return
+160.38%
AUM
$202M
AUM Growth
-$25.5M
(-11%)
Cap. Flow
+$3.24M
Cap. Flow
% of AUM
1.6%
Top 10 Holdings %
Top 10 Hldgs %
26.95%
Holding
105
New
5
Increased
30
Reduced
44
Closed
24
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Target
TGT
|
+$5.28M |
| 2 |
United Parcel Service
UPS
|
+$4.03M |
| 3 |
Cisco
CSCO
|
+$3.53M |
| 4 |
State Street
STT
|
+$3.3M |
| 5 |
Corning
GLW
|
+$3.28M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$3.24M |
| 2 |
Cardinal Health
CAH
|
+$3.1M |
| 3 |
Gilead Sciences
GILD
|
+$3.06M |
| 4 |
Philip Morris
PM
|
+$2.07M |
| 5 |
Newmont
NEM
|
+$1.75M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.92% |
| 2 | Financials | 16.81% |
| 3 | Healthcare | 14.24% |
| 4 | Consumer Discretionary | 9.42% |
| 5 | Consumer Staples | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66B
| $7.1M | 3.52% |
88,761
+849
| +1% | +$69.3K |
|
2
Tyson Foods
TSN
$21B
| $6.33M | 3.14% |
73,548
-781
| -1% | -$70K |
|
3
Molson Coors Class B
TAP
$7.86B
| $6.18M | 3.06% |
113,332
-861
| -0.8% | -$46.2K |
|
4
Microsoft
MSFT
$3.62T
| $5.21M | 2.58% |
20,302
+71
| +0.4% | +$19.3K |
|
5
Blackrock
BLK
$175B
| $5.06M | 2.51% |
8,308
+41
| +0.5% | +$26.7K |
|
6
Pfizer
PFE
$143B
| $5.06M | 2.51% |
96,467
-127
| -0.1% | -$6.47K |
|
7
Huntington Bancshares
HBAN
$35.1B
| $5.03M | 2.49% |
418,253
+26,129
| +7% | +$347K |
|
8
Devon Energy
DVN
$51.4B
| $4.94M | 2.45% |
89,560
+1,250
| +1% | +$81.6K |
|
9
EOG Resources
EOG
$77.6B
| $4.77M | 2.36% |
43,173
-51
| -0.1% | -$6.33K |
|
|
10
Newmont
NEM
$100B
| $4.69M | 2.33% |
78,646
-24,682
| -24% | -$1.75M |
|
11
Johnson & Johnson
JNJ
$613B
| $4.41M | 2.18% |
24,819
-169
| -0.7% | -$30.1K |
|
12
Intel
INTC
$459B
| $4.36M | 2.16% |
116,481
+898
| +0.8% | +$38.9K |
|
13
Viatris
VTRS
$20.5B
| $4.25M | 2.11% |
406,178
-3,893
| -0.9% | -$42.7K |
|
14
Ericsson
ERIC
$33.1B
| $4.21M | 2.08% |
568,207
+376,362
| +196% | +$3.07M |
|
15
Invesco
IVZ
$13.6B
| $4.19M | 2.08% |
259,560
+47,335
| +22% | +$896K |
|
|
16
United Parcel Service
UPS
$90.8B
| $4.03M | 2% |
+22,083
| New | +$4.03M |
|
17
Citigroup
C
$224B
| $3.94M | 1.95% |
85,694
+2,403
| +3% | +$120K |
|
|
18
Target
TGT
$67.8B
| $3.89M | 1.93% |
+27,549
| New | +$5.28M |
|
19
NetApp
NTAP
$35.9B
| $3.85M | 1.91% |
58,998
+12,458
| +27% | +$896K |
|
|
AVGOP
20
DELISTED
Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A
AVGOP
| $3.77M | 1.87% |
2,505
+24
| +1% | +$42.3K |
|
21
iShares Preferred and Income Securities ETF
PFF
$13.3B
| $3.74M | 1.85% |
113,813
+4,225
| +4% | +$143K |
|
22
CVS Health
CVS
$134B
| $3.5M | 1.74% |
37,786
-485
| -1% | -$47.3K |
|
23
UnitedHealth
UNH
$377B
| $3.49M | 1.73% |
6,803
-187
| -3% | -$93.9K |
|
24
IBM
IBM
$213B
| $3.47M | 1.72% |
24,603
-373
| -1% | -$50.3K |
|
25
International Paper
IP
$21.9B
| $3.46M | 1.71% |
82,655
-194
| -0.2% | -$9K |
|
Similar funds
MWM
PCC
CF
SGCM
RCWM
LCA
WHCI
FPWM
Palouse Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, Palouse Capital Management held 105 positions worth $202M, down 11% from $227M the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Palouse Capital Management's Q2 2022 filing shows 5 new, 30 increased, 44 reduced and 24 closed positions. Its largest new stake was Target: 27,549 shares worth $3.89M. The largest sale was Merck, an estimated $3.24M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- Palouse Capital Management's largest Q2 2022 buy was Target: 27,549 shares worth $3.89M.
- Palouse Capital Management added most to Ericsson in Q2 2022, an estimated $3.07M increase.
- Palouse Capital Management's biggest Q2 2022 reduction was Newmont, cutting an estimated $1.75M.
- Palouse Capital Management fully exited Merck in Q2 2022, selling an estimated $3.24M.
- Palouse Capital Management's ten largest holdings make up 27% of its $202M portfolio in Q2 2022.
- Palouse Capital Management opened 5 new positions and closed 24 in Q2 2022.
- Palouse Capital Management's portfolio value fell 11% quarter-over-quarter to $202M.
Based on Palouse Capital Management's 13F filing for Q2 2022, filed 28 Jul 2022.